| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/10/2023 | 0.51% | Citigroup | $48 → $49 | Maintains | Neutral |
| 09/22/2023 | 21.03% | Wolfe Research | → $59 | Initiates Coverage On | → Outperform |
| 09/19/2023 | — | JMP Securities | Initiates Coverage On | → Market Perform | |
| 08/04/2023 | 6.67% | Barclays | $51 → $52 | Maintains | Overweight |
| 08/04/2023 | 8.72% | Wells Fargo | $50 → $53 | Maintains | Overweight |
| 05/05/2023 | 2.56% | Wells Fargo | $49 → $50 | Maintains | Overweight |
| 04/18/2023 | -7.69% | Citigroup | $44 → $45 | Maintains | Neutral |
| 03/01/2023 | 0.51% | Wells Fargo | $47 → $49 | Maintains | Overweight |
| 02/21/2023 | -28.21% | Autonomous Research | → $35 | Initiates Coverage On | → Underperform |
| 01/20/2023 | 4.62% | BMO Capital | → $51 | Initiates Coverage On | → Outperform |
| 01/18/2023 | -3.59% | Wells Fargo | $45 → $47 | Maintains | Overweight |
| 12/16/2022 | -7.69% | Wells Fargo | $41 → $45 | Upgrades | Equal-Weight → Overweight |
| 12/15/2022 | -13.85% | Citigroup | → $42 | Initiates Coverage On | → Neutral |
| 11/11/2022 | -5.64% | RBC Capital | $47 → $46 | Maintains | Sector Perform |
| 11/11/2022 | -15.9% | Wells Fargo | $44 → $41 | Maintains | Equal-Weight |
| 10/03/2022 | — | JP Morgan | Downgrades | Neutral → Underweight | |
| 08/12/2022 | — | RBC Capital | Downgrades | Outperform → Sector Perform | |
| 07/12/2022 | -3.59% | Goldman Sachs | → $47 | Upgrades | Neutral → Buy |
| 05/13/2022 | -26.15% | Wells Fargo | $38 → $36 | Maintains | Equal-Weight |
| 03/16/2022 | -22.05% | Wells Fargo | $41 → $38 | Maintains | Equal-Weight |
| 03/16/2022 | -13.85% | RBC Capital | $40 → $42 | Maintains | Outperform |
| 01/06/2022 | -9.74% | Barclays | $43 → $44 | Maintains | Overweight |
| 01/04/2022 | -15.9% | Wells Fargo | $37 → $41 | Maintains | Equal-Weight |
| 08/20/2021 | — | William Blair | Initiates Coverage On | → Outperform | |
| 08/17/2021 | -34.36% | Wolfe Research | → $32 | Initiates Coverage On | → Peer Perform |
| 08/16/2021 | -26.15% | UBS | → $36 | Initiates Coverage On | → Buy |
| 08/16/2021 | -36.41% | Wells Fargo | → $31 | Initiates Coverage On | → Equal-Weight |
| 08/16/2021 | -32.31% | Goldman Sachs | → $33 | Initiates Coverage On | → Neutral |
| 08/16/2021 | -36.41% | JP Morgan | → $31 | Initiates Coverage On | → Neutral |
| 08/16/2021 | -30.26% | RBC Capital | → $34 | Initiates Coverage On | → Outperform |
| 08/16/2021 | -28.21% | Barclays | → $35 | Initiates Coverage On | → Overweight |
What is the target price for Ryan Specialty Hldgs (RYAN)?
The latest price target for Ryan Specialty Hldgs (NYSE: RYAN) was reported by Citigroup on October 10, 2023. The analyst firm set a price target for $49.00 expecting RYAN to rise to within 12 months (a possible 0.51% upside). 15 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Ryan Specialty Hldgs (RYAN)?
The latest analyst rating for Ryan Specialty Hldgs (NYSE: RYAN) was provided by Citigroup, and Ryan Specialty Hldgs maintained their neutral rating.
When is the next analyst rating going to be posted or updated for Ryan Specialty Hldgs (RYAN)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Ryan Specialty Hldgs, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Ryan Specialty Hldgs was filed on October 10, 2023 so you should expect the next rating to be made available sometime around October 10, 2024.
Is the Analyst Rating Ryan Specialty Hldgs (RYAN) correct?
While ratings are subjective and will change, the latest Ryan Specialty Hldgs (RYAN) rating was a maintained with a price target of $48.00 to $49.00. The current price Ryan Specialty Hldgs (RYAN) is trading at is $48.75, which is within the analyst's predicted range.